Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help

Browse Research Outcomes

Author/s:Wu, Fang; Cristofoletti, Rodrigo; Zhao, Liang; Rostami-Hodjegan, Amin
Date:04/01/2021
Journal:Biopharmaceutics & Drug Disposition
DOI:10.1002/bdd.2274